Osteoarthritis (OA) is a condition affecting millions of patients around the world, causing pain and disability and often resulting in joint replacement surgery. The aetiology of OA has long been attributed to mechanical wear mainly due to the increased prevalence of OA in load bearing joints among older patients. However, recent studies reveal a complex molecular disease causality in which inflammation, nutritional deficit and angiogenesis lead to the destruction of the joint structure. The aim of this study was to examine chemokine receptor expression in peripheral blood and bone marrow in OA patients. We devised a protocol for extracting healthy bone marrow from patients undergoing hip arthroplasty due to coxarthrosis. Flow cytometry was used to determine the expression of 18 chemokine receptors on CD4 and CD8 T cells from bone marrow and blood from 7 osteoarthritis patients and peripheral blood from 9 healthy controls. We found a significantly increased fraction of CCR2 expressing CD4 and CD8 T cell in peripheral blood compared to healthy controls. Also, there was a significant decrease in CXCR3 (Th1) (P < 0.01) expressing T cells in peripheral blood from OA patients. Finally, multivariate analysis was used to separate T cell profiles from healthy controls and OA patients and demonstrate that the divergence of chemokine receptor expression occurs in the mature T cell subsets. In conclusion, we find increased CCR2 expression in peripheral blood from OA patients that possibly may be targeted in future clinical studies.
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| INTRODUCTION
Osteoarthritis (OA) develops when the cartilage of joints is destroyed which leads to joint dysfunction and pain, affecting millions of patients around the world. 1 Gradually diminished joint cartilage is associated with ossification of cartilage and bone remodelling, with increased density of cortical bone and formation of subchondral cysts and osteophytes which together form the radiological hallmarks of osteoarthritis. 2 Cartilage ossification and joint dysfunction are however poorly correlated with the disabling pain associated with OA. 3 Joint cartilage normally lacks innervation and blood supply. Nutrients are instead carried by the synovial fluid through the permeable cartilage as the joint is compressed and decompressed during motion. An overwhelming body of evidence suggests that this nutritional support is essential for cartilage repair and is disrupted by obesity or immobilization.
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pain associated with OA. 4 Additionally, neuropathic pain arising from the dorsal root ganglion has been displayed in animal models of OA. 5 Recruitment of microglia into the dorsal root ganglion has been shown to cause hyper-excitability of sensory neurons with increased pain sensibility. [6] [7] [8] This process has been suggested to governed by MCP-1 expression attracting CCR2 expressing monocytes from peripheral blood. 5 Chondrocytes also express MCP-1 which could attract monocytes in a similar fashion. 9 These monocytes in turn drive the inflammation and subsequently secrete VEGF and other vessel attractants leading to increased vascularization from the subchondral bone and subsequent vessel innervation. 10, 11 MCP-1 has also been shown to directly stimulate angiogenesis through the expression of CCR2 on endothelial cells. 6, 12 The vascularization from the bone surface is followed by ossification resulting in some of the radiological findings seen with disease progression. 4 Chemokine receptors are seven-transmembrane G protein-coupled receptors that convey their function by inducing cell transmigration towards a chemokine concentration gradient where one chemokine receptor may display affinity for multiple ligands. Their function of promoting chemotaxis makes them essential in a wide range of biological events from inflammation to organogenesis during foetal development. Chemokine receptor expression is also used for phenotyping leucocyte populations where the expression of CXCR3, CCR4, CCR6 and CCR7 on CD4 + T helper cells will suggest a lineage commitment towards Th1 (CXCR3), Th2 (CCR4) and Th17 (CCR6) and aid in identifying memory cells (CCR7). 13 
| MATERIALS AND METHODS

| Patient samples
Peripheral blood and bone marrow were obtained from patients (n = 7) undergoing elective total hip arthroplasty surgery due to osteoarthritis. Research subjects were enrolled at hospital admission after informed consent. Within the Swedish healthcare system, patients with radiological hallmarks of OA are eligible for surgery when satisfactory pain relief cannot be obtained without oral opioid analgesia. Patients with malignancies or on immunosuppressive drugs were excluded from the study as well as patients with coagulation deficiencies. Additionally, peripheral blood was obtained from healthy blood donors (n = 9) as control. Ethical permission was granted by the local ethical committee in accordance with the declaration of Helsinki.
Trabecular bone fragments containing marrow material were obtained from the proximal femur during arthroplasty surgery and transported in 50 mL falcon tubes containing 30 mL RPMI cell medium with the addition of methicillin, streptomycin and 5000 IU of heparin. Additionally, 20 mL of peripheral blood was drawn using heparinized tubes prior to surgery. All samples were transported, prepared and kept at room temperature. PBMCs from OA patients and healthy controls were purified from peripheral blood using density gradient separation and washed twice in phosphate buffered saline (PBS). The bone marrow samples were partitioned using a cannula and then crushed in a petri dish using a 50 mL pipette under sterile conditions at room temperature. The crushed sample was then filtered through a 100 μm cell strainer and flushed with RPMI 1640. The filtrate was purified from bone fragments and fat residue using density gradient separation. Extracted cell was then lysed using ACK buffer and washed 3 times in PBS to obtain pure leucocytes and finally diluted to a concentration of 1 million cells per mL in PBS containing 5% of the patients own heparinized serum. Cell count and cell viability were assessed by Countess Automated Cell Counter (Invitrogen, Carlsbad, California, USA). Average leucocyte viability for bone marrow was 68% and yields more that 100 million cells per bone marrow sample. Bone marrow samples were transported prepared and stained under 6 hours while peripheral blood samples typically were drawn 3 hours prior to bone marrow samples were available (average yield 20 million cells with 74% viability).
| Flow cytometry
Peripheral blood and bone marrow-derived leucocytes were stained for chemokine receptor and phenotypic markers using an antibody panel according to Table S1 . After staining, cells were washed twice in PBS containing 5% of patients own sera and analysed by flow cytometry on FACS CANTO II (Becton, Dickinson, San Jose, CA, USA). Gating was performed using BD DIVA and FlowJo software.
After gating out singlet cells based FSH-A and FSH-linearity, lymphocytes were gated on morphology. Lymphocytes were then gated on CD3 + and CD4 + .The CD3 + CD4 -were designated as CD8 + and the CD3 + CD4 + designated CD4 + . These populations were further subdivided into naïve CD45RA + and memory CD45RA -cells, the latter being considered CD45RO positive. The CD45RA gate was set using the CD3 -lymphocyte population which displayed a clear distinction between the positive and the negative population. Binding of antibody to each chemokine receptor was compared with isotype and fluorophore identical controls to remove effects of unspecific binding where a 2% overlap with the isotype staining was considered acceptable. ( Figure S1) 
| Statistical analysis
To enable PCA analysis, cases with missing data were imputed by the median of that chemokine receptor in the entire dataset, thereby reducing the differences between the groups. The number of cases with missing data is found in Table S2 . Principal component analyses (PCAs) were run using the FactomineR package in R. 14 Briefly, principal component analysis is a dimensionality reduction technique that performs an orthogonal linear transformation of multidimensional data onto a 2D plane. The two axes or dimensions are the two principal components (combinations of variables) that capture as much as possible of the variance in the dataset. This allows visualizing how closely related different samples are in a multidimensional space, and which variables make them differ from each other (separation on either of the PCA axes). We used sample origin, CD4, CD8 and CD45RA status (all binarized) as quantitative supplementary variables. Thus, we could study how these descriptors related to the pattern of chemokine receptor expression in the 2D plane formed by the two first principal components. Differences between groups were also assessed using the two-tailed Student's t test. Paired t tests were used for differences between blood and bone marrow samples from the same patient. To correct for multiple testing, Benjamini-Hochberg correction was applied. All presented P-values were adjusted for multiple testing. Adjusted P-values <0.05 were considered significant.
| RESULTS
| Chemokine receptor expression on peripheral blood T cells from osteoarthritis patients
When comparing the percentage of T cells expressing chemokine receptors in peripheral blood from OA patients and healthy controls, we found a significantly decreased fraction of naïve CD4 
| Chemokine receptor expression on bone marrow-derived T cells from osteoarthritis patients
Contrasting naïve CD4 + CD45RA + peripheral blood T cells from OA patients with paired cells from bone marrow, no significant difference was noted ( Figure 1A ). However, among CD8 + CD45RA + T cell a significantly increased fraction of cells carry CCR2 (P < 0.001), CXCR1 (P < 0.05) and also CX3CR1 (P < 0.05) in peripheral blood. (Figure 1B ). In memory CD4 + CD45RO + T cells, the percentage of CCR2, CCR4, CCR7 and CCR10 were significantly increased in the periphery (P < 0.01, 0.01, 0.01 and 0.05, respectively), whereas CCR5 was significantly decreased (P < 0.01) in peripheral blood compared to bone marrow. (Figure 1C ). Memory CD8 + CD45RO
+ showed a similar pattern with increased fraction of cells carrying CCR2 (P < 0.001), CCR4 (P < 0.05), CCR6 (P < 0.05) and CCR7 (P < 0.001), in peripheral blood compared to bone marrow while again CCR5 showed significantly reduced levels (P < 0.05). (Figure 1D) 
| Increase in circulating CCR2 T cells in patients with osteoarthritis
Most noticeable, CCR2 on circulating T cells from patients with OA were differently expressed than in bone marrow and healthy control blood ( Figure S2 ). All T cell subsets displayed an increased proportion of CCR2 expressing cells in peripheral blood from OA patients. Naïve Next, we evaluated the expression of CCR2 on T cells from bone marrow derived from OA patients ( Figure S2 ). The fraction of CCR2 expressing T cells was significantly decreased in bone marrow of OA patients compared to their peripheral blood. (P < 0.01) ( Figure S2 ). However, the fraction of CCR2 expressing T cells in the bone marrow from OA patients did not differ significantly from CCR2 expressing T cells in peripheral blood of healthy controls. Thus, we conclude that there is an increased fraction of CCR2 expressing CD4 and CD8 in peripheral blood from OA patients. 
F I G U R E 1 A) Expression of 18 chemokine receptor in naïve CD4
+ CD45RA + in OA bone marrow and peripheral blood (n = 7) and peripheral blood from healthy controls(n = 9). Pairwise multiple t test comparison of chemokine receptor expression in bone marrow and peripheral blood from OA patients and unpaired multiple t test comparison between peripheral blood from OA patients and healthy controls. Significant difference indicated by *P < 0.05, **P < 0.01, ***P < 0.001. B) Expression of 18 chemokine receptor in CD8 + CD45RA + in OA bone marrow and peripheral blood (n = 7) and peripheral blood from healthy controls (n = 9). Pairwise multiple t test comparison of chemokine receptor expression in bone marrow and peripheral blood from OA patients and unpaired multiple t test comparison between peripheral blood from OA patients and healthy controls. Significant difference indicated by *P < 0.05, **P < 0.01, ***P < 0.001. C) Expression of 18 chemokine receptor in memory CD4 + CD45RO + in OA bone marrow and peripheral blood(n = 7) and peripheral blood from healthy controls (n = 9). Pairwise multiple t test comparison of chemokine receptor expression in bone marrow and peripheral blood from OA patients and unpaired multiple t test comparison between peripheral blood from OA patients and healthy controls. Significant difference indicated by *P < 0.05, **P < 0.01, ***P < 0.001. D) Expression of 18 chemokine receptor in memory CD8 + CD45RO + in OA bone marrow and peripheral blood (n = 7) and peripheral blood from healthy controls (n = 9). Pairwise multiple t test comparison of chemokine receptor expression in bone marrow and peripheral blood from OA patients and unpaired multiple t test comparison between peripheral blood from OA patients and healthy controls. Significant difference indicated by *P < 0.05, **P < 0.01, ***P < 0.001 CCR2 and CCR5 with the addition of CXCR1 and low levels of CCR7, while the opposite was seen in bone marrow. A list of all chemokine receptors and sample variables correlating significantly with the 2nd PCA dimension, meaning that they are the variables mainly responsible for differences between samples, is found in Table S3 .
| Memory T cells diverge in chemokine receptor expression
The expression of chemokine receptors on CD45RA + T cells remains homogenous. Naïve CD45RA + CD4 + T cells did not show any significant differences in chemokine receptor expression between peripheral blood and bone marrow from OA patients ( Figure 1C ). In contrast, the fraction of T cells expressing CD45RO + was significantly different from bone marrow and peripheral blood (Figure 1D) . Thus, the major differences seen in the T cells chemokine receptor expression between bone marrow and the periphery were found in the memory T cell subset.
( Figure 1C,D) . In summary, PCA and multiple t testing indicate that memory CD45RO Table S3 ).
| DISCUSSION
We find that peripheral blood-derived T cells from OA patients display a distinct chemokine receptor repertoire, both when compared to healthy controls and to paired bone marrow. Most striking is the marked upregulation in CCR2 expressing cells in peripheral blood which is not seen in paired bone marrow. The memory CD45RO + T cell subsets are clearly more diverse in chemokine receptor expression.
OA peripheral blood CD4 + T cells display a tendency towards a Th2 phenotype and OA peripheral blood T cells show a general expression pattern correlating with CD8 and CD45RO on PCA. The adaptive immune system has previously been implicated in OA pathogenesis and the strongest support for this is the disease correlation with HLA alleles. 15 Some animal models have also shown involvement of CD4 T cell in disease progression. 16 In our material, we see a significant decrease of CXCR3 and a nonsignificant increase of CCR4 on T cells in peripheral blood from OA patients suggesting a skewing towards Th2 phenotype in patients with OA. Joint infiltrating T cells in OA have predominantly displayed a Th1 phenotype in why F I G U R E 2 Principal component analyses on peripheral blood and bone marrow from OA patients and peripheral blood from OA patients and healthy controls. Arrows show how sample categories correlate with the three principal dimensions. Although samples do not form separate clusters based on origin, there is significant separation between peripheral T cells from patient with OA (yellow) and bone marrow derived from OA patient (blue) and between peripherally derived T cells from OA patients and healthy controls (green) in the second dimension when assed pairwise; peripheral T cells from OA patient having a memory effector CD8+CD45RO+ like chemokine expression profile with a strong significant correlation with the second dimension characterized by high levels of CCR2 and CCR5 and low levels of CCR7, while the opposite was seen in healthy control blood and OA bone marrow this finding is surprising. 17, 18 As the CXCR3-CXCL10 migration pathway has previously been implicated in development and progression of experimental OA, why one could speculate that the decreased levels of Th1 phenotype T cells in peripheral blood during OA might be a result of increased migration into the affected joints. 19 Thus, a Th2 skewed profile in peripheral blood may inversely reflect the translocation of Th1 cell into the joint. We also note that the chemokine receptor repertoire remains relatively homogeneous in the CD45RA + T cell populations and do not differ greatly between OA and healthy peripheral blood and is characterized by high levels of CCR7 both in peripheral blood and in bone marrow, although with higher levels in bone marrow as expected.
Our data indicate that as the T cells mature into a memory CD45RO + phenotype in the periphery, the spectra of chemokine receptors diverge into tissue-and diseasespecific subsets. However, limitations in our fluorophore panel did not permit us to distinguish the terminally differentiated TEMRA CD45RA+ populations nor for double positive CD4 + CD8 + or double negative CD8 -CD4 -T cell populations.
The most notable finding is the difference in CCR2 expression levels between bone marrow and peripheral blood. OA and CCR2 expression is generally associated with monocytes and CCR2 has been shown to regulate the egress of monocytes from the bone marrow niche. 20 The process is believed to work by heterologous desensitization of anchoring CXCR4 in the bone marrow by ligand binding to CCR2. 21 The low levels of CCR2 on T cells in bone marrow suggest a similar effect of CCR2 for T lymphocytes. The possibility of monocyte contamination was excluded given that all populations were clearly CD3 + and all doublets eliminated. Also, overall chemokine repertoire differs greatly from that of monocytes (ie, CCR1). 22 However, given the high level of CCR2, a CD14 dump gate would have been desirable. Synovial and serum concentration of the CCR2 ligand MCP-1 has previously been shown to vary with disease activity in OA. 23 Interestingly, mice deficient in CCR2 do not develop neuropathic pain as do WT mice in experimental OA 5 and experience reduced neuropathic pain when subjected to nerve injury. 24 The mechanism suggested involves diminished monocyte/microglia recruitment to dorsal root ganglion causing increased excitability of sensory neurons. 7 However, MCP-1 is produced by synovial fibroblast during joint inflammation 25 and also under hypoxic conditions 26 and MCP-1 has been shown to have angiogenic properties 12 which could tribute to the vessel and subsequent nerve protrusion from the subchondral bone surface ultimately leading to joint innervation. 11 Chemokine receptors such as CCR2 and CCR5 are expressed on damaged nociceptive neurons. 6 CCR5 has previously been shown increased in synovial fluid of OA but not in peripheral blood. 18 In our hands, we see a significantly higher number of CCR5 + CD45RO + T cells in bone marrow than in peripheral blood of OA patients. However, although not significant using multiple t testing, CCR5 together with CCR2 display a significant, strong and positive correlation with OA peripheral blood on PCA when compared with healthy control blood ( Figure 2 , Table S3 ). A confounding factor when analysing chemokine receptor expression in painful disorders like OA is that most patients undergoing surgery are often subjected to pretreatment with opioids prior to surgery and most receive oral opioid analgesia in the final stages of osteoarthritis prior to joint replacement surgery. Opioids, like chemokines, convey their action by seven-transmembrane G protein-coupled receptors. The influence of opioids on migratory functions has been well studied revealing a mechanism of heterologous desensitization of chemokine receptors including CCR2 during agonist binding to the δ-and μ-opiate receptor but not with the κ-receptor. 27 The migratory properties are impeded due to phosphorylation of the intracellular domain of the chemokine receptor leaving the extracellular portion of the receptor intact and surface bound but unresponsive. 28 Interestingly, only agonist binding of μ-and δ-opiate receptor results in diminished migration towards MCP-1 and these receptor share G protein-linked receptor kinases (GRK3) with the CCR2b isoform and CCR5. 29 In addition, some studies suggest that this mechanism of opioid/chemokine cross-desensitization might be irreversible. 30 Indeed intraarticular administered opiates have shown greater long-term pain reduction than similarly administered steroids supporting this notion 31 although conflicting results exit for short-term treatment. [32] [33] [34] In conclusion, through analysing the chemokine receptor repertoire in osteoarthritis, we found that osteoarthritis is characterized by a distinct chemokine receptor pattern in peripheral blood. We find that the differences in chemokine receptor repertoire on T cells are mainly due to divergence of memory T cells in the periphery. Of the receptors studied, CCR2 showed the most striking overexpression in peripheral circulation of OA patients and could represent a target for future treatment. Hypothetically, local and shortterm treatment with opioids might be more beneficial to OA patients leading to heterologous desensitization of CCR2 with diminished innervation, vascularization and pain of the affected joints. Alternately, small molecules type drug might be used for CCR2 blockage.
Although these findings are intriguing and provide and insight to the complexity of T cell phenotyping and migration characteristics, the setup of this study was mainly focused on hypothesis generating rather than hypothesis testing and as such is in need of confirmation. Flow cytometry including FMO controls together with genomic and/or proteomic methods would greatly strengthen these findings. However, restriction in the ethical permit limited our possibility to conduct these controls during the course of this study. Furthermore, the pharmacological effect of opioids and other commonly used pharmaceuticals needs to be given increased attention.
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